Jop H. van Berlo
-
- Cardiac Fibrosis and Remodeling 17
- Cardiomyopathy and Myosin Studies 8
- Molecular Biology top 2%
- Congenital heart defects research 22
- Signaling Pathways in Disease 7
- Nuclear Structure and Function 6
- Pluripotent Stem Cells Research 5
- Immunology top 5%
- Surgery top 5%
- Tissue Engineering and Regenerative Medicine 11
- Cancer Research top 5%
-
- Peptidase Inhibition and Analysis 4
- Co-authors
- Jeffery D. MolkentinMarjorie MailletYigal M. PintoHarry J.G.M. CrijnsOnur KanisicakFederica AccorneroRonald J. VagnozziSaraswati Pokharel
- Journals
- Circulation Research (10 papers)Circulation (4 papers)Journal of Molecular and Cellular Cardiology (3 papers)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Jop H. van Berlo
51 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Cardiology and Cardiovascular Medicine 1.6k
- Molecular Biology 3.0k
- Immunology 632
- Surgery 1.0k
- Cancer Research 320
Countries citing papers authored by Jop H. van Berlo
This map shows the geographic impact of Jop H. van Berlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jop H. van Berlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jop H. van Berlo more than expected).
Fields of papers citing papers by Jop H. van Berlo
This network shows the impact of papers produced by Jop H. van Berlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jop H. van Berlo. The network helps show where Jop H. van Berlo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jop H. van Berlo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 1 | |
| 4 | 2023 | 23 | |
| 5 | 2022 | 25 | |
| 6 | 2021 | 1 | |
| 7 | 2020 | 1 | |
| 8 | 2020 | 6 | |
| 9 | 2020 | 25 | |
| 10 | 2018 | 6 | |
| 11 | 2018 | 52 | |
| 12 | 2017 | 27 | |
| 13 | 2014 | 180 | |
| 14 | 2013 | 340 | |
| 15 | 2013 | 28 | |
| 16 | 2006 | 1 | |
| 17 | 2005 | 129 | |
| 18 | 2004 | 301 | |
| 19 | Sudden death can not be prevented by pacemaker therapy in patients with lamin A/C mutations | 2002 | 2 |
| 20 | Clinical characteristics of genetic dilated cardiomyopathy differ between sarcomeric and non-sarcomeric gene mutations | 2002 | 1 |
About Jop H. van Berlo
Jop H. van Berlo is a scholar working on Cardiology and Cardiovascular Medicine, Structural Biology and Molecular Biology, having authored 55 papers that have together received 4.4k indexed citations. Recurring topics across this work include Congenital heart defects research (22 papers), Cardiac Fibrosis and Remodeling (17 papers), Tissue Engineering and Regenerative Medicine (11 papers), Cardiomyopathy and Myosin Studies (8 papers), Signaling Pathways in Disease (7 papers), Nuclear Structure and Function (6 papers), Pluripotent Stem Cells Research (5 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.6k citations), Molecular Biology (3.0k citations) and Immunology (632 citations). Jop H. van Berlo has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Jeffery D. Molkentin, Marjorie Maillet, Yigal M. Pinto, Harry J.G.M. Crijns, Onur Kanisicak, Federica Accornero, Ronald J. Vagnozzi, Saraswati Pokharel, Umesh C. Sharma and Thomas J. van Brakel. Their work appears in journals such as Circulation Research, Circulation, Journal of Molecular and Cellular Cardiology, Nature and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.